Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

PRPO

Precipio Inc

Apr 16 • 11:40AM ET

6.63

Dollar change -0.11
Percentage change -1.61	%

Healthcare • Diagnostics & Research • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VXF VTI

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-4.89	Insider Own	4.41%	Shs Outstand	1.42M	Perf Week	1.80%
Market Cap	9.08M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	1.31M	Perf Month	6.89%
Income	-5.85M	PEG	-	EPS next Q	-0.70	Inst Own	10.81%	Short Float	0.40%	Perf Quarter	11.75%
Sales	15.20M	P/S	0.60	EPS this Y	106.24%	Inst Trans	-17.54%	Short Ratio	0.75	Perf Half Y	-1.38%
Book/sh	10.16	P/B	0.65	EPS next Y	-	ROA	-29.56%	Short Interest	0.01M	Perf Year	-46.57%
Cash/sh	1.09	P/C	6.05	EPS next 5Y	20.00%	ROE	-38.09%	52W Range	4.75 - 15.41	Perf YTD	1.95%
Dividend Est.	-	P/FCF	-	EPS past 5Y	56.09%	ROI	-39.12%	52W High	-57.00%	Beta	1.23
Dividend TTM	-	Quick Ratio	1.05	Sales past 5Y	43.42%	Gross Margin	37.17%	52W Low	39.47%	ATR (14)	0.30
Dividend Ex-Date	-	Current Ratio	1.17	EPS Y/Y TTM	54.47%	Oper. Margin	-50.14%	RSI (14)	55.56	Volatility	4.67% 4.87%
Employees	57	Debt/Eq	0.08	Sales Y/Y TTM	61.46%	Profit Margin	-38.51%	Recom	1.00	Target Price	19.00
Option/Short	No / Yes	LT Debt/Eq	0.04	EPS Q/Q	132.46%	Payout	-	Rel Volume	0.06	Prev Close	6.74
Sales Surprise	2.68%	EPS Surprise	14.05%	Sales Q/Q	81.05%	Earnings	Nov 20 BMO	Avg Volume	7.04K	Price	6.63
SMA20	4.68%	SMA50	3.92%	SMA200	-1.06%	Trades		Volume	164	Change	-1.61%

Apr-01-24 10:53AM	PRPO Stock Earnings: Precipio Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
Mar-25-24 05:00PM	Precipio Announces Year end 2023 Shareholder Update Call (GlobeNewswire)
Feb-13-24 10:00AM	Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY (GlobeNewswire)
Feb-06-24 10:00AM	Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen Portfolio of Molecular assays for Cancer (GlobeNewswire) +8.24%
Jan-23-24 10:00AM	Precipio's Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter (GlobeNewswire)
10:30AM	Loading…
Jan-17-24 10:30AM	Precipio Signs Distribution Agreement For IV-Cell and HemeScreen in Japan (GlobeNewswire) +15.37%
Jan-02-24 09:00AM	Precipio Announces Christina Valauri joins the Board of Directors (GlobeNewswire)
Dec-14-23 04:30PM	Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024 (GlobeNewswire) +12.40%
Nov-16-23 05:00PM	Precipio Announces Q3-2023 Shareholder Update Call (GlobeNewswire)
Oct-18-23 09:00AM	Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022 (GlobeNewswire)
Oct-03-23 10:00AM	Precipio's Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023 (GlobeNewswire)
Sep-28-23 09:00AM	Precipio Continues to Sign New HemeScreen Customers (GlobeNewswire)
Sep-25-23 11:00AM	Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven (GlobeNewswire)
Sep-21-23 09:00AM	Precipio Takes Final Step Towards Regaining Nasdaq Compliance (GlobeNewswire) -10.41%
Sep-13-23 09:30AM	Precipios Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan (GlobeNewswire) +7.80%
03:26PM	Loading…
Aug-31-23 03:26PM	11 ChatGPT Penny Stock Picks (Insider Monkey)
Aug-19-23 06:01AM	Precipio, Inc. (NASDAQ:PRPO) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-13-23 10:16AM	Precipio, Inc.'s (NASDAQ:PRPO) Shares Not Telling The Full Story (Simply Wall St.)
Aug-10-23 05:00PM	Precipio Announces Q2-2023 Shareholder Update Call (GlobeNewswire)
Aug-08-23 09:00AM	Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel (GlobeNewswire)
Aug-03-23 09:00AM	Precipios Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakeven (GlobeNewswire)
Aug-01-23 09:00AM	Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023 (GlobeNewswire) +5.74%
Jun-14-23 09:49AM	Precipios Omnia Methodology Enables Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow Biopsy (GlobeNewswire)
Jun-13-23 09:00AM	Precipio Enters into Collaboration with Prestigious New York-based Institution to Develop Revolutionary Brain Tumor Panel using HemeScreen® Technology (GlobeNewswire)
Jun-08-23 08:30AM	Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement (GlobeNewswire) -29.40%
Jun-07-23 09:30AM	Projected cash burn reduced by $1.5 million annually from Three Operational Efficiency Projects (GlobeNewswire) +15.23%
May-22-23 11:00AM	Precipios Lab Detects BCR-ABL1 Oncogene Co-Expression of p190 & p210 Isoforms in a CML Patient By Using HemeScreen® Technology (GlobeNewswire)
May-17-23 04:00PM	Precipio Shares Growth Catalysts For HemeScreen (GlobeNewswire)
May-15-23 04:00PM	Precipio Announces Q1-2023 Shareholder Update Call (GlobeNewswire)
May-04-23 01:00PM	Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division (GlobeNewswire) -6.71%
10:00AM	Loading…
10:00AM	Precipio Signs Another HemeScreen Customer (GlobeNewswire)
Apr-27-23 05:00PM	Precipio Granted 180-day Extension From NASDAQ To Regain Compliance (GlobeNewswire)
Apr-19-23 11:00AM	Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combined (GlobeNewswire)
Apr-09-23 10:25AM	Precipio, Inc. (NASDAQ:PRPO) Q4 2022 Earnings Call Transcript (Insider Monkey)
Apr-02-23 08:55AM	Precipio Full Year 2022 Earnings: US$0.54 loss per share (vs US$0.40 loss in FY 2021) (Simply Wall St.)
Mar-28-23 05:00PM	Precipio Announces 2022 Fourth Quarter and Year-End Shareholder Update Call (GlobeNewswire)
Mar-21-23 10:30AM	Precipio Ships First IV-Cell® Order to Major US Healthcare System (GlobeNewswire)
Mar-07-23 12:49PM	CORRECTION -- Precipio continues to sign up and onboard HemeScreen customers (GlobeNewswire)
12:00PM	Precipio continues to sign up and onboard HemeScreen customers (GlobeNewswire)
Feb-14-23 11:44AM	ThermoFisher Salesforce Votes Precipios HemeScreen® as Best New Product (GlobeNewswire)
Jan-11-23 10:00AM	Precipio Signs Another Major HemeScreen Customer (GlobeNewswire) +7.21%
Dec-06-22 10:00AM	Precipio Signs Additional Major HemeScreen Customer (GlobeNewswire)
Nov-07-22 10:30AM	Precipio Presents Poster on HemeScreen® Study at Association of Molecular Pathology (AMP) 2022 Annual Conference (GlobeNewswire)
Nov-02-22 05:00PM	Precipio Announces Third Quarter Shareholder Update Call (GlobeNewswire)
Oct-18-22 09:07AM	Precipio, Inc. (NASDAQ:PRPO) Is Expected To Breakeven In The Near Future (Simply Wall St.)
Sep-15-22 11:00AM	Precipio Signs Agreement with Another Major US Healthcare Distributor for HemeScreen (GlobeNewswire) +8.33%
Aug-24-22 11:00AM	Sharon Robins Joins Precipios Products Division as Senior Director of Laboratory & Hospital Sales (GlobeNewswire)
Aug-16-22 11:00AM	Precipio Launches New 1-Step Technology for all HemeScreen Assays (GlobeNewswire) -10.67%
Aug-10-22 10:00AM	Toni-Ann Mills Joins Precipios Products Division to Lead Channel Partner Training, Learning & Development (GlobeNewswire)
Aug-08-22 10:00AM	Precipio Announces Second Quarter Shareholder Update Call (GlobeNewswire)
Jul-20-22 10:30AM	Precipio to distribute HemeScreen® through Fisher Healthcare channel (GlobeNewswire)
Jun-14-22 02:00PM	Precipio requests that all Stockholders that have not yet voted, proceed to cast their vote (GlobeNewswire)
Jun-13-22 11:00AM	Keith Meadors Joins Precipio to Lead its Products Division (GlobeNewswire) -9.40%
May-24-22 10:30AM	Precipio Receives CE-IVD Certification to Market Multiple HemeScreen® Panels in Europe (GlobeNewswire)
May-11-22 08:15AM	When Will Precipio, Inc. (NASDAQ:PRPO) Breakeven? (Simply Wall St.) -11.40%
May-10-22 10:30AM	Precipio Signs First IV-Cell Customer Agreement (GlobeNewswire) +15.91%
Apr-26-22 10:00AM	Precipio customer American Oncology Network (AON) selected to present HemeScreen® technology case study at Industry leading clinical laboratory conference (GlobeNewswire)
Mar-22-22 06:00PM	Precipio Announces 2021 Fourth Quarter and Year-End Shareholder Update Call (GlobeNewswire)
Mar-21-22 05:00PM	Precipio Inc. Announces the Resignation of its Chief Financial Officer and Appointment of Interim CFO (GlobeNewswire)
Feb-24-22 10:00AM	Precipio Releases Year-End 2021 Preliminary Unaudited Results and Outlook for 2022 (GlobeNewswire)
Nov-29-21 07:27AM	Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) +7.33%
Nov-18-21 10:00AM	New York State Approves Precipios HemeScreen for POL clinical use (GlobeNewswire)
Nov-03-21 08:00AM	89bio Announces Appointment of Kathy LaPorte to its Board of Directors (GlobeNewswire)
Nov-01-21 05:00PM	Precipio Announces Q3-2021 and year-end Shareholder Update Call (GlobeNewswire) +10.38%
03:54PM	Precipio (NASDAQ:PRPO) shareholders have endured a 44% loss from investing in the stock three years ago (Simply Wall St.)
Aug-26-21 10:00AM	American Oncology Network Partners with Precipio to Bring HemeScreen® into AONs Laboratory (GlobeNewswire) +5.52%
Aug-20-21 05:00PM	Precipio Reschedules Q2-2021 Shareholder Update Call (GlobeNewswire)
Aug-13-21 10:48AM	Precipio Corrects Announcement of Q2-2021 Shareholder Update Call (GlobeNewswire)
Aug-12-21 05:00PM	Precipio Announces Q2-2021 and year-end Shareholder Update Call (GlobeNewswire)
Jul-28-21 10:00AM	Precipio Announces Preliminary Unaudited Q2-2021 Revenues of $2.3M (GlobeNewswire)
Jun-15-21 11:00AM	Precipio Terminates its Equity Line (GlobeNewswire) -5.51%
Jun-08-21 10:30AM	Precipio Launches HemeScreen® Anemia Panel, a One-of-its-Kind Testing Tool (GlobeNewswire) +18.47%
May-20-21 03:15PM	Precipio, Inc. to Host Earnings Call (ACCESSWIRE) +14.77%
May-14-21 04:30PM	Precipio Announces Q1-2021 and year-end Shareholder Update Call (GlobeNewswire) +15.27%
May-10-21 10:30AM	Precipio Launches New HemeScreen Panel for AML, with an unparalleled 4-hour turnaround-time (GlobeNewswire) +15.62%
May-05-21 10:14AM	Investors Who Bought Precipio (NASDAQ:PRPO) Shares A Year Ago Are Now Up 688% (Simply Wall St.)
May-04-21 02:41PM	Indias COVID-19 case tally tops 20 million after nearly doubling in three months (MarketWatch) +6.06%
07:42AM	UPDATE: Precipio shares soar 32% premarket after rapid COVID test becomes available on Amazon (MarketWatch)
04:43AM	Precipio Maintains Momentum After 172% Jump (TheStreet.com)
04:42AM	Premarket Movers Tuesday - Pfizer, CVS Health, Precipio (TheStreet.com)
May-03-21 10:41AM	Precipio Soars on Launch of COVID-19 Antibody Test on Amazon (TheStreet.com) +171.98%
09:30AM	Precipio Launches its Rapid COVID-19 Antibody test on Amazon Platform (GlobeNewswire)
Apr-26-21 11:00AM	Current Signed Customers Expected to Generate $1M Annualized Reported Revenues from Precipios HemeScreen POL Offering by Q4-2021 (GlobeNewswire)
Apr-05-21 09:00AM	Precipio Enters Into an At-The -Market (ATM) Financing Arrangement (GlobeNewswire)
Mar-31-21 03:15PM	Precipio, Inc. to Host Earnings Call (ACCESSWIRE)
Mar-30-21 09:00AM	Precipio Announces 95% Annual Growth YoY and 180% Quarterly Growth YoY (GlobeNewswire) +7.17%
Mar-18-21 04:30PM	Precipio Announces Q4-2020 and year-end Shareholder Update Call (GlobeNewswire)
Mar-03-21 01:00PM	Mr. Ron Andrews joins Precipios Board of Directors (GlobeNewswire) -5.98%
11:00AM	Mr. Richard Sandberg is appointed Chairman of Precipios Board of Directors (GlobeNewswire)
Jan-28-21 09:30AM	Precipio Launches COVID-19 Antibody Testing at Point-of-Care (GlobeNewswire) -6.97%
Jan-20-21 10:00AM	Precipio Signs HemeScreen Deals with Two Leading Oncology Groups (GlobeNewswire)
Dec-10-20 10:15AM	Precipio Signs Sales & Marketing Agreement for HemeScreen with Major Oncology Distributor (GlobeNewswire)
Nov-19-20 03:15PM	Precipio, Inc. to Host Earnings Call (ACCESSWIRE)
Nov-11-20 09:00AM	Precipio Announces Q3-2020 Shareholder Update Call (GlobeNewswire)
Oct-06-20 10:00AM	Precipio & ADS Biotec Launch Seven Beta sites for IV-Cell (GlobeNewswire) -6.69%
Sep-22-20 10:30AM	Precipio Launches its Proprietary HemeScreen AML (Acute Myeloid Leukemia) Molecular Panel (GlobeNewswire)
Sep-04-20 09:00AM	Precipio Announces a Shareholder Call to Discuss its COVID-19 Progress and Future Plans (GlobeNewswire) +12.50%
Aug-20-20 01:00PM	Precipio & ADS Biotec Sign Global Distribution Agreement for IV-Cell (GlobeNewswire) +6.25%
Aug-07-20 09:00AM	Precipio Announces Q2-2020 Corporate Update Call For Shareholders (GlobeNewswire) -8.67%
Aug-04-20 10:45AM	Precipio Launches Covid-19 Antibody Test in its CLIA laboratory (GlobeNewswire) +25.24%

Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HemeScreen Panel, and ICE COLD-PCR. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PRPO

Precipio Inc

Upgrade your FINVIZ experience